相关实验视频
Updated: Jul 21, 2026

09:11
Genome Editing with CompoZr Custom Zinc Finger Nucleases ZFNs
Published on: June 14, 2012
25.6K
在人类牙细胞中使用指核酶编辑人类白细胞抗原位置的等位基因选择性基因组编辑
Izumi Kuroda1,2, Tomoko Kawaguchi3, Shunji Chikusa2
1Anesthesiology, Laboratory of Molecular Design and Synthesis, Gifu University Graduate School of Medicine, Gifu, JPN.
Cureus
|June 27, 2025
概括
基因编辑可以通过破坏特定的人类白细胞抗原 (HLA) 的等位基因来创建伪同卵性牙纤维细胞 (DPC). 这种方法提高了细胞治疗的DPC兼容性,扩大了潜在的捐赠者池.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 全基性人类牙纸细胞 (DPC) 显示出治疗潜力,但由于人类白细胞抗原 (HLA) 不兼容性而面临限制.
- 为多种人群采购HLA单双型同卵性 (HHH) 捐赠体具有挑战性,阻碍了广泛的DPC应用.
- 通过基因编辑生成伪HHH DPC,为克服HLA障碍提供了一个有希望的策略.
研究的目的:
- 建立指核酶 (ZFN) 介导的基因编辑,用于DPC中的HLA-A的等位基因特异性破坏.
- 评估针对HLA-A*02:01等位基因的ZFN的效率和特异性.
- 评估基因编辑DPC的基因稳定性和HLA兼容性.
主要方法:
- 在特定的DPC中设计和应用针对HLA-A*02:01等位基因的ZFN.
- 光激活细胞分类 (FACS) 用于细胞丰富后转化.
- 使用针对性深度测序,全基因组测序 (WGS) 和基于下一代测序 (NGS) 的HLA类型的基因编辑结果的评估.
主要成果:
- 实现了对目标HLA-A*02:01等位基因的高效 (>96%的indels) 和特异性破坏.
- 观察到非向的HLA-A*33:03等位基因的最小修饰.
- 在非编码区域,WGS显示了总体基因组稳定性与小的SV;NGS证实了HLA位点完整性.
结论:
- 通过ZFN介导的等位基特异性HLA淘汰对于生成伪HHH DPC是可行的.
- 这种基因编辑方法可能会扩大基于DPC的再生医学的捐赠池.
- 彻底的基因组完整性评估对于这些修饰DPC的临床转化至关重要.
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Conservative Site-specific Recombination and Phase Variation
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

